A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

A new University of Michigan study shows that a strong majority of older Americans want health insurance — including Medicare — to cover weight loss medica ...

State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...

Dr Harriet Treacy, co-founder of Beyondbmi, spoke with EVOKE to explain that obesity is a disease that requires medical treatment, whereas many people are simply availing of the drugs to lose a few ...

are denied coverage for anti-obesity medications, even though these treatments have been shown to reduce weight, improve overall health, prevent or manage obesity-related conditions, and for some ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Popular anti-diabetes and obesity drug Mounjaro has been launched in India in a single-dose vial. While it has already been ...

Popular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...